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Abstract
The immune suppression that characterizes human helminth infections can hinder the development
of protective immunity or help reduce pathogenic inflammation. Signaling through the T cell co-
stimulator GITR counteracts immune down-regulation by augmenting effector T cell responses
and abrogating suppression by Foxp3+ regulatory T cells. Thus, super-physiological antibody-
mediated GITR co-stimulation represents a novel therapy for promoting protective immunity
towards parasitic helminths, whilst blocking physiological GITR-GITRL interactions may provide
a mechanism for dampening pathogenic Th2 inflammation. We investigated the super-
physiological and physiological role of the GITR-GITRL pathway in the development of
protective and pathogenic Th2 responses in murine infection models of filariasis (Litomosoides
sigmodontis) and schistosomiasis (Schistosoma mansoni). Providing super-physiological GITR
co-stimulation using an agonistic anti-GITR mAb over the first 12 days of L. sigmodontis
infection initially increased the quantity of Th2 cells as well as their ability to produce Th2
cytokines. However, as infection progressed the Th2 responses reverted to normal infection levels
and parasite killing remained unaffected. Despite the Th2 promoting role of super-physiological
GITR co-stimulation, antibody-mediated blockade of the GITR-GITRL pathway did not affect
Th2 cell priming or maintenance during L. sigmodontis infection. Blockade of GITR-GITRL
interactions during the acute egg-phase of S. mansoni infection resulted in reduced Th2 responses,
but this effect was confined to the spleen and did not lead to changes in liver pathology. Thus,
although super-physiological GITR co-stimulation can therapeutically enhance Th2 responses,
physiological GITR-GITRL interactions are not required for the development of Th2-mediated
resistance or pathology in murine models of filariasis and schistosomiasis.
Introduction
Human helminth infections are characterized by immune suppression resulting in parasite
survial and chronic infection (1-3). Chronically infected filarial and schistosome patients
present impaired immune responses as shown by reduced IL-5 and IFN-γ, and occasionally
IL-4, production in response to parasite antigens (4-7). Although some elements of immune
suppression are reversible upon drug-mediated clearance (6, 8), drug treatments do not
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induce immune protection against parasite challenge and individuals rapidly become
reinfected. Strategies to induce long-term protective immunity are therefore needed that can
counteract infection-induced immune regulation.
The Glucocorticoid-Induced TNF Receptor-related protein (GITR) is a co-stimulatory
receptor and a member of the tumor necrosis factor receptor superfamily (9-11). It is
constitutively expressed at high levels on Foxp3+ regulatory T cells (Tregs) and at low
levels on naïve CD4+ T cells, and expression increases in both cell populations upon
activation (12). The ligand for GITR (GITRL) is highly expressed on activated
plasmatocytoid DC (13, 14) and macrophages (15). Co-stimulation through GITR augments
CD4+ effector T (Teff) cell responses (12, 16) and by enhancing CD4+ Teff cell activation
can abrogate Foxp3+ Treg mediated suppression (14, 17). Therefore, GITR co-stimulation
provides a potential strategy for counteracting immune regulation and boosting immune
responses. We and others have demonstrated that agonistic anti-GITR mAb treatment can
enhance immunity to helminth parasites (18, 19), and similar results have been found with
other infections (20-22) and tumors (23, 24). As such there is growing interest in employing
GITR co-stimulation as a novel vaccine adjuvant (25-28). On the counter side, GITR
ligation can exacerbate pathology during bacterial or protozoan infections (29, 30),
suggesting that blocking GITR-GITRL interactions could be used to alleviate pathology.
Most studies have focussed on the effects of agonistic anti-GITR co-stimulation, yet these
super-physiological effects of GITR ligation might be quite different from natural ligation
through GITRL. Few studies have shown a physiological role for GITR-GITRL interactions
during immune challenge, all of which are Th1 related (13, 31-33). Thus, the physiological
roles of GITR are not well defined, particularly in regard to Th2 responses.
Infection of resistant (C57BL/6) and susceptible (BALB/c) mice with the filarial nematode
Litomosoides sigmodontis provides a unique model to dissect out the mechanisms of
immune regulation in Th2-mediated resistance to helminths (34). In a complementary
system, infection of mice with the trematode Schistosoma mansoni allows the study of
pathogenic Th2 responses towards the highly immunogenic Th2-driving eggs that become
trapped in tissue microvasculature, such as the liver, resulting in granuloma formation (35).
We have demonstrated that L. sigmodontis infection induces an early Foxp3+ Treg response
that in susceptible mice inhibits protective immunity and promotes parasite survival (19, 36,
37). Resistant C57BL/6 mice show equivalent early Foxp3+ Treg responses, but in contrast
they simultaneously present a more active CD4+Foxp3− Teff cell response with upregulation
of GITR. This raises an interesting question of what role GITR plays in priming and
maintaining Th2 effector responses, and/or in their resistance to Foxp3+ Treg mediated
suppression. The balance of which may influence protective immunity during filarial
infection.
Although susceptible BALB/c mice develop a down-regulated immune phenotype leading to
a fully developed patent infection 55 – 60 days p.i. (19, 36, 37), defined by the presence of
transmission stage microfilariae (Mf) circulating within the blood (34), they do eventually
overcome immune-regulation resulting in late-phase killing and clearance of L. sigmodontis
after 70 days (34, 38, 39). GITR expression on BALB/c CD4+Foxp3− T cells increases
during the later stages of infection (19, 36), and super-physiological GITR co-stimulation
can be used therapeutically alongside depleting CD4+CD25+Foxp3+ Tregs to enhance
parasite killing (19). Thus, GITR co-stimulation may also be involved in the reversal of
immune-regulation and late-phase parasite killing following patency.
We tested the super-physiological and physiological roles of the GITR-GITRL pathway in
the development and maintenance of protective Th2 responses during filarial infection, and
pathogenic Th2 responses during S. mansoni infection. Providing super-physiological GITR
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co-stimulation during immune priming using an agonistic anti-GITR mAb increased Th2
responses towards L. sigmodontis in susceptible BALB/c mice. However, these augmented
Th2 responses were short-lived and did not result in a long-term enhancement of protective
immunity. Blocking physiological GITR-GITRL interactions with a neutralizing anti-
GITRL mAb during L. sigmodontis infection did not inhibit Th2 priming in resistant
C57BL/6 mice, nor the late-phase parasite-clearance in susceptible BALB/c mice. Whilst
GITRL blockade during the egg-deposition stage of S. mansoni infection had a partial effect
on the expansion of splenic IL-4 producing Th2 cells, it had no significant impact on liver
granuloma formation. Thus, although superphysiological GITR co-stimulation enhanced
Th2 responses during filarial infection, physiological GITR-GITRL interactions were
neither a prerequisite for resistance, nor a requirement for the induction or maintenance of
Th2 responses. Similarly, GITR-GITRL interactions were not required for the development
of Th2-mediated immunopathology during S. mansoni infection.
Materials and Methods
Animals, infections, antigen, and immunizations
Female BALB/c, C57BL/6 and BALB/c 4get IL-4gfp reporter mice (courtesy of Markus
Mohrs, The Trudeau Institute) (40) were bred in-house and maintained under specific
pathogen-free conditions at the University of Edinburgh. Mice were used at 6-12 weeks of
age, and all animal work was conducted in accordance with the Animals (Scientific
Procedures) Act 1986. The L. sigmodontis life cycle was maintained in gerbils using the
mite vector Ornithonyssus bacoti (41). Mice were infected s.c. on the upper back with 25 L.
sigmodontis L3 larvae. Adult parasites were recovered by lavage. L. sigmodontis antigen
(LsAg) was prepared by collecting the PBS-soluble fraction of homogenized adult male and
female worms. Biomphalaria glabrata snails infected with S. mansoni were obtained from F.
Lewis (Biomedical Research Institute, Rockville, MD). Experimental mice were infected
percutaneously with approximately 30 S. mansoni cercariae. S. mansoni eggs were
quantified following liver digestion in 4% potassium hydroxide buffer per gram liver tissue
at 37°C. To measure liver granulomas, paraffin embedded liver sections were stained with
Masson’s trichrome and the area of each granuloma containing a single egg calculated using
a compound microscope (LEICA) and LEICA analysis software (LAS). From this the
average granuloma size for each individual mouse was calculated. S. mansoni eggs were
isolated from C57BL/6 mouse livers and stored at −80°C. S. mansoni soluble egg Ag was
prepared in-house as previously described (42). Mice were immunized s.c. in the footpad
with 1500 S. mansoni eggs.
In vivo antibody and BrdU treatments
Mice received i.p. injections of 1 mg agonistic anti-GITR mAb (DTA-1, in house) (17) on
d0 and d7 of L. sigmodontis infection. To block GITRL, mice were given i.p. injections with
200 μg anti-GITRL mAb (MIH44, in house) (43) every three days. Treatment started on d0
or d59 of L. sigmodontis infection, d0 of S. mansoni egg injection, and d36 following S.
mansoni infection. An equivalent dose of rat IgG (Sigma-Aldrich) was used as control. For
BrdU treatment, mice received an i.p. injection of 1mg BrdU (Sigma-Aldrich) 24 hours prior
to autopsy.
Cell purifications and in vitro restimulations
The parathymic, posterior, mediastinal and paravertebral LN, were taken as a source of
thoracic LN draining the pleural cavity (tLN). Pleural cavity cells were recovered by lavage.
MLN, tLN, and spleen cells were dissociated and washed in RPMI-1640 (invitrogen)
supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 2mM L-glutamine, and
either 0.5% mouse sera (Caltag-Medsystems) for L. sigmodontis studies or 5% FCS for S.
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mansoni studies. To purify GFP−CD4+ T cells from IL-4gfp mice tLN cells were enriched
for CD4+ T cells by negative selection using anti-CD8 (53-6.72), anti-B220 (RAB632), anti-
MHC class II (M5/114.15.2), anti-Gr1 (RB6-8C5) and anti-F4/80 (A3-1), followed by sheep
anti-rat IgG Dynal Beads (Invitrogen). Cells were stained with allophycocyanin-conjugated
anti-CD4 (RM4-5) and GFP−CD4+ T cells purified using a FACSAria flow sorter (Becton-
Dickinson). To isolate liver mononuclear cells the liver was diced and digested at 37°C with
250 μg/ml Collagenase D and 10 μg/ml DNase in Hanks’ medium supplemented with 50 U/
ml penicillin-50 μg/ml streptomycin. To stop the enzymatic digestion 100 μl 0.1 M EDTA
pH 7.3 was added. To obtain a single-cell suspension the digest was passed through a 70 μm
cell strainer (BD Biosciences). Leukocytes were isolated by resuspension in 33% isotonic
Percoll (GE Healthcare) and centrifugated at 700 g. For restimulation with LsAg (10μg/ml)
or S. mansoni SEA (15μg/ml) whole tLN cells were cultured at 5×105 cells/well and spleen
cells at 1×106 cells/well. Purified GFP−CD4+ T cells were cultured at 5×104 cells/well with
1×106 irradiated (30 Gy) naïve splenocytes. Supernatants were harvested at 72 hours. To
measure intra-cellular cytokines cells were stimulated for 4 hours with 0.5 μg/ml PMA
(Sigma-Aldrich) and 1 μg/ml Ionomycin (Sigma-Aldrich), with 10 μg/ml Brefeldin A added
for the final 2 hours (Sigma-Aldrich).
Flow cytometry
The following antibodies were used: Alexafluor700-conjugated anti-CD4 (RM4-5),
polyclonal anti-GFP (Ebioscience), Alexafluor488-conjugated goat anti-rabbit IgG
(Invitrogen), phycoerythrin-conjugated anti-IL-4 (11B11), Alexafluor647-conjugated anti-
IL-13 (ebio13A, Ebioscience), allophycocyanin-conjugated anti-IL-5 (TRFK5), E450-
conjugated anti-IFN-γ (XMG1.2, Ebioscience), Fluorescein isothiocyanate-conjugated anti-
GITR (DTA-1, in house), Fluorescein isothiocyanate-conjugated anti-BrdU with DNase
(B44) and allophycocyanin -conjugated anti-Foxp3 (FJK-16s, Ebioscience). Non-specific
binding was blocked with 4 μg of rat IgG/1×106 cells. Intracellular staining for Foxp3 was
performed with a Foxp3-staining buffer kit (eBioscience). For intracellular cytokine staining
dead cells were excluded using Aqua Dead Cell Stainkit (Molecular Probes), and the cells
fixed and permeabilized using the BD Cytofix/Cytoperm kit. Flow cytometric acquisition
was performed on a FACSCanto II or LSR II (BD Biosciences) and data were analyzed
using Flowjo Software (Tree Star). Reagents were obtained from BD Biosciences unless
otherwise stated.
Cytokine and antibody ELISA
Antibody pairs used for cytokine ELISA were IL-4 (11B11/BVD6-24G2); IL-5 (TRFK5/
TRFK4); IL-10 (JES5-2A5/SXC-1); IFN-γ (R4-6A2/XMG1.2); capture anti-IL-13 (38213,
R&D systems); and biotinylated polyclonal anti-IL-13 (Peprotech). Recombinant murine
IL-4, IL-5, IL-10, IFN-γ (Sigma-Aldrich), and IL-13 (R&D Systems) were used as
standards. Biotin detection antibodies were used with ExtrAvidin-alkaline phosphatase
conjugate (Sigma-Aldrich) and Sigma FastTM p-nitrophenyl phosphate substrate (Sigma-
Aldrich). To measure L. sigmodontis specific antibodies ELISA plates (NUNC) were coated
with 5 μg/ml LsAg diluted in 0.45M NaHCO3/0.18M Na2CO3 (Sigma-Aldrich). Plates were
incubated with serial dilutions of serum, and a representative dilution from the linear section
of the dilution curve selected for each isotype. Detection of Ab isotypes was performed
using HRP-conjugated anti-mouse IgG1, IgG2a or IgM (Southern Biotechnology
Associates) and ABTS peroxidase substrate system (KPL).
Statistics
Statistical analysis was performed using JMP version 8. The data were first checked for
homogeneity of variance and normality. If the raw data failed to meet these requirements for
parametric analysis log10 transformations were applied. Parametric analysis of combined
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data from multiple repeat experiments, or experiments containing more than two groups,
was performed using ANOVA followed by Tukey’s post-hoc tests. When using two-way
ANOVA to combine data from multiple experiments it was verified that there were no
significant qualitative interactions between experimental and treatment effects. For non-
parametric data the unpaired Mann–Whitney test was used. Figures depict means when
parametric tests were used and medians when non-parametric tests were used.
Results
Th2 responses are retarded during the initial stages of L. sigmodontis infection
Th2 responses are critical for resistance towards L. sigmodontis (44, 45). However, it has
been difficult to accurately quantify Th2 responses in the early stages of infection. To track
Th2 cell development during L. sigmodontis infection susceptible BALB/c 4get IL-4gfp
reporter mice (46) were infected and the percentage of CD4+IL-4gfp+ Th2 cells in the
pleural cavity (infection site) and tLN quantified over the course of infection. The
development of Th2 responses during the early infection stages was slow with no initial
increase over naives in the proportion of IL-4gfp+ Th2 cells in the pleural cavity at d6 p.i.,
and only a weak, albeit significant, 2-fold increase in the proportion of IL-4gfp+ Th2 cells at
d12 p.i. (Fig. 1A). The weak nature of the d12 increase was notable by the fact that it did not
reach significance within every individual experiment, although significant when meta-
analysis was used to combine data from multiple experiments. Not until the later stages of
infection did the proportion of IL-4gfp+ Th2 cells gradually increase with a 6-fold expansion
by d40 p.i., when adult parasites have developed, and a 17-fold increase after the onset of
patency at d60 p.i. (Fig 1A). A similar pattern was found within the tLN, with a modest
initial expansion followed by a gradual increase to reach a 4-fold up-regulation at d60 p.i.
(Fig. 1B). Thus, the initial Th2 response to L. sigmodontis is remarkably slow to emerge,
becoming robust only during the later infection stages.
Therapeutic administration of anti-GITR during immune priming enhances the magnitude
of the Th2 response
We have previously shown that resistance to L. sigmodontis infection in C57BL/6 mice is
associated with increased expression of GITR on CD4+Foxp3− Teff cells during the early
infection stages, whilst susceptible BALB/c mice fail to up-regulate GITR and show reduced
CD4+Foxp3− Teff cell proliferation (36). To test the hypothesis that providing super-
physiological GITR co-stimulation could be used to boost the initial Th2 responses and
reverse susceptibility, we infected BALB/c IL-4gfp reporter mice with L. sigmodontis and
treated them with agonistic anti-GITR mAb at d0 and d7 p.i. Treatment resulted in a 60%
increase in the frequency of IL-4gfp+ Th2 cells in the pleural cavity 12 days p.i. (Fig. 2A).
This increment was restricted to the infection site as although anti-GITR treatment increased
the percentage of IL-4gfp+ Th2 cells in the tLN this was independent of infection (Fig. 2B).
Despite the augmented Th2 differentiation, anti-GITR did not increase the numbers of total
cells or CD4+ T cells in the tLN or pleural cavity (data not shown).
In 4get reporter mice, GFP+ cells are those that express IL-4 mRNA and are competent to
produce IL-4, but the GFP label does not necessarily mark the production of IL-4 protein
(40). To confirm that anti-GITR treatment increases the production of Th2 cytokines we
assessed the ability of IL-4gfp+ Th2 cells in the pleural cavity to produce IL-4, IL-5, and
IL-13 by intra-cellular staining for protein. Whilst infection alone at this early timepoint
only caused a minor non-significant increase in the proportion of IL-4gfp+ Th2 cells
producing IL-5 and IL-13 (Fig 2D-E), anti-GITR treatment of infected mice significantly
increased the percentage of IL-4gfp+ Th2 cells producing IL-4, IL-5 and IL-13 (Fig. 2C-E).
Although anti-GITR treatment did not increase the percentage of IL-4gfp+ Th2 cells in the
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tLN in response to infection, it did result in increased L. sigmodontis Ag-specific IL-5
production following in vitro restimulation of tLN cells (Fig. 2F). IL-4 and IL-13 were not
consistently detectable following in vitro restimulation emphasizing the weak nature of the
early Th2 response (data not shown). In line with Th2 induction, L. sigmodontis infection
tends to reduce the proportion of CD4+ T cells producing IFN-γ, however, in addition to its
effects on Th2 immunity, anti-GITR treatment increased the proportion of pleural cavity
CD4+ T cells producing IFN-γ 12 days p.i. (Fig. 2G).
To investigate whether anti-GITR treatment also boosts humoral immunity, we determined
the levels of L. sigmodontis Ag-specific antibodies in the serum 12 days p.i.. Despite
enhancing the cellular Th2 response, anti-GITR treatment did not result in increased
production of the Th2 antibody isotype IgG1 (Fig. 2H). However, the increased production
of IFN-γ was associated with elevated levels of serum IgG2a (Fig. 2I). Serum IgM, IgG2b,
and IgG3 were unaffected by anti-GITR treatment (data not shown).
Thus, super-physiological GITR co-stimulation during immune priming enhances both Th1
and Th2 responses to L. sigmodontis, with the increased Th2 immunity at the infection site
due to both elevated numbers of IL-4gfp+ Th2 cells and increased functional quality of the
Th2 population as measured by their production of Th2 cytokines.
Therapeutic administration of anti-GITR during immune priming fails to increase parasite
killing and results in a long-term enhancement of Th1, but not Th2, immunity
For anti-GITR treatment to be effective as an adjuvant or therapeutic agent it would need to
induce a long-term change in protective immunity. Therefore, we asked whether agonistic
anti-GITR treatment results in a permanent or temporary enhancement of Th2 responses.
Susceptible BALB/c IL-4gfp+ reporter mice were treated with anti-GITR on d0 and d7 p.i.
and autopsied at d60 when Mf are circulating in the bloodstream.
By d60 p.i. L. sigmodontis infected mice have established a stronger Th2 response with
34±9% of CD4+ T cells in the pleural cavity expressing IL-4gfp (Fig 3A) compared to
5±5% at d12 (Fig. 1A). Despite the early boosting effect of anti-GITR treatment on Th2
responses there were no differences in the proportion (Fig. 3A-B) or number (results not
shown) of IL-4gfp+ Th2 cells between anti-GITR treated and IgG infected mice by 60 days
p.i.. There were also no differences in the L. sigmodontis Ag-specific production of IL-5
(Fig. 3C), IL-4 or IL-13 (data not shown) by tLN following in vitro restimulation. Consistent
with the failure to induce a long-term increase in Th2 immunity, adult parasite burdens and
Mf counts in peripheral blood remained unaffected following anti-GITR treatment (Figs.
3D-E).
In agreement with the transitory nature of the enhanced cellular Th2 response we did not
find any long-term effect of anti-GITR treatment on L. sigmodontis-specific serum levels of
IgG1 (Fig. 3F). However, L. sigmodontis-specific IgG2a was still elevated in the sera at d60
p.i. (Fig. 3G), and IFN-γ production by purified tLN IL-4gfp− non-Th2 cells was enhanced,
albeit in an antigen non-specific manner (Fig. 3H). Thus, the augmenting effects of anti-
GITR treatment on Th2 priming appear to be temporary, and do not result in increased
parasite killing. In contrast, even though L. sigmodontis infection mainly induces a Th2
response anti-GITR treatment resulted in a minor, but long-term, enhancement of Th1
immunity.
GITR-GITRL interactions are not required for priming of Th2 responses to L. sigmodontis
Resistant C57BL/6 mice up-regulate GITR on CD4+Foxp3− Teff cells during the early
stages of L. sigmodontis infection suggesting that their stronger initial Teff cell response and
resistance may be related to GITR co-stimulation (36). To determine whether GITR-GITRL
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interactions are required for the development of Th2 responses and resistance to filarial
infections, we treated L. sigmodontis infected C57BL/6 mice over the first 12 days of
infection with an anti-GITRL mAb that has been shown to block GITRL activity in vivo
(13, 24, 43).
GITRL blockade failed to reduce the proportion of CD4+Foxp3− Teff cells proliferating in
vivo in response to infection, thus GITR-GITRL interactions could not explain the enhanced
effector T cell response of resistant C57BL/6 mice (Fig. 4A). Similarly, GITR-GITRL
interactions were not required for the induction of Th2 responses as the production of L.
sigmodontis Ag-specific IL-5 and IL-13 by tLN cells was unaffected (Fig. 4B, 4C). GITRL
blockade also failed to impact on the resistant phenotype with both control and anti-GITRL
treated mice showing similar parasite recoveries at d47 p.i. (data not shown). These data
suggest that although super-physiological GITR co-stimulation can enhance Th2 responses
during priming, physiological GITR-GITRL interactions are not required for Th2 priming
following L. sigmodontis infection.
GITR-GITRL interactions are not required for late-phase killing of L. sigmodontis
Although patency is associated with immune down-regulation (19, 36, 37), BALB/c mice
show a late-phase killing response and clear infection after 70 days (34, 38, 39). We have
found that expression of GITR on Foxp3− Teff cells at the infection site increases as
infection progresses, and that treating infected mice with agonistic anti-GITR antibody
during established infection can promote protective immunity (19, 36). These results raise
the hypothesis that late-phase killing is due to increasing levels of GITR co-stimulation
naturally boosting Th2 cell responses and leading to a reversal in immune regulation.
To investigate this possibility, L. sigmodontis infected susceptible BALB/c mice, either
wild-type or IL-4gfp reporter mice, were treated with a blocking anti-GITRL mAb from
d60-80 p.i.. Despite high levels of GITR expression (19, 37), blockade of GITRL was not
found to impact on parasite burden or Mf levels 82 days p.i. (Fig. 5A-B). Accordingly, no
differences were seen in the total number of IL-4gfp+ Th2 cells in the pleural cavity (Fig.
5C) or the tLN (Fig. 5D), or the proportion of pleural cavity IL-4gfp+ Th2 cells producing
IL-4 and IL-5 protein (data not shown). In vitro L. sigmodontis Ag-specific production of
IL-5 (Fig. 5E) and IL-4 (data not shown) by tLN cells also remained unaltered. Thus, GITR-
GITRL interactions are not required for Th2 maintenance or late-phase killing during L.
sigmodontis infection.
GITR-GITRL interactions are partially required for Th1 and Th2 responses during S.
mansoni infection
Infection with S. mansoni results in immunopathology when eggs become trapped in the
liver microvasculature, resulting in immune inflammation and granuloma formation (35).
We found that expression of GITR is strongly upregulated on CD4+Foxp3− Teff cells in the
spleen and liver at the peak of egg-induced inflammation (week 8 p.i.) (Fig. 6A-B)
suggesting that GITR signaling is potentiating the inflammatory Th2 response. We therefore
tested whether blocking GITR-GITRL interactions can be used to moderate Th2 mediated
inflammation and granuloma formation during S. mansoni infection.
As early infection with L. sigmodontis larvae induces a relatively weak Th2 response and
increases in IL-4 protein are difficult to detect, we injected S. mansoni eggs s.c. to confirm
the role of GITR-GITRL interactions in the context of a stronger Th2 stimulus. In this
setting, 11% of CD4+ T cells expressed IL-4gfp 10 days post-injection, however, GITRL
blockade still failed to affect Th2 cell priming as the total number of IL-4gfp+ Th2 cells in
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the draining popliteal LN (Fig. 6C), as well as the total number of IL-4gfp+ Th2 cells
producing IL-4 (data not shown) remained unaltered.
To investigate whether GITR-GITRL interactions promote egg-induced Th2 responses
during S. mansoni infection, BALB/c IL-4gfp reporter mice were treated with blocking anti-
GITRL mAb from the stage of initial egg deposition (wk 5 p.i.) until the time of peak
inflammation (wk 8 p.i.). Blockade of GITRL resulted in a significant 43% reduction in the
number of IL-4gfp+ Th2 cells expressing IL-4 protein in the spleen (Fig. 6D). Despite the
reduced number of IL-4gfp+ Th2 cells secreting IL-4 protein in the spleen there was no
effect on S. mansoni egg Ag-specific splenic production of IL-4, IL-5, IL-10 or IL-13
following in vitro restimulation (data not shown). Consistent with a partial reduction in Th2
responses, GITRL blockade had no effect on the proportion of IL-4gfp+ Th2 cells secreting
IL-4 protein in the liver (Fig. 6E), and also no effect on the size of egg-induced liver
granulomas (Fig. 6F). As well as a diminished Th2 response, there was a small but
consistently significant reduction in the proportion of IFN-γ producing CD4+ T cells in the
spleen (Fig. 6G) and liver (Fig. 6H). Thus, in contrast to L. sigmodontis infection, blockade
of GITR-GITRL interactions partially reduces both Th2 and Th1 responses towards S.
mansoni.
GITR-GITRL interactions are not required for Foxp3+ Treg expansion following helminth
infection
L. sigmodontis infection results in the rapid expansion of GITR+Foxp3+ Tregs at the
infection site in both susceptible and resistant mice (36). There are conflicting reports that
GITR co-stimulation promotes Foxp3+ Treg expansion (13, 18, 32, 43, 47) so to test
whether GITR-GITRL interactions are responsible for the initial Foxp3+ Treg expansion
GITRL was blocked over the first 12 days of L. sigmodontis infection in resistant C57BL/6
mice. As previously shown there was an increased percentage of CD4+ T cells expressing
Foxp3 in the pleural cavity of L. sigmodontis infected mice, but this was unaffected by
blockade of GITRL (Fig. 7A). In the converse experiment, treating susceptible BALB/c
mice with agonistic anti-GITR mAb on d0 and d7 p.i. also failed to affect the percentage of
CD4+ T cells expressing Foxp3 (Fig. 7B). Similarly, blockade of GITRL during the acute
egg phase of S. mansoni infection (wk 5-8 p.i.) had no effect on Foxp3+ Treg expansion in
the spleen (Fig. 7C) or liver (Fig. 7D). Thus, GITR-GITRL interactions do not play a major
role in the expansion of Foxp3+ Tregs during L. sigmodontis or S. mansoni infections.
Discussion
Co-stimulation of GITR through agonistic mAb is known to augment effector T cell
responses (10, 16), overcome Foxp3+ Treg mediated suppression (14, 17), and boost
resistance to infection with helminths, protozoa, and viruses (18-21, 48), demonstrating the
potential for targeting GITR as a therapeutic adjuvant. In contrast to this super-physiological
GITR co-stimulation, understanding of the physiological role of GITR is limited,
particularly in Th2 settings. In the present study we investigated both the super-
physiological and physiological role of the GITR-GITRL pathway in the development and
maintenance of protective and pathogenic Th2 and Foxp3+CD4+ Treg responses in murine
models of filariasis and schistosomiasis. Providing super-physiological GITR co-stimulation
using agonistic anti-GITR mAb during immune priming initially augmented Th2 responses
towards the filarial nematode L. sigmodontis. However, this effect was temporary with the
Th2 response reverting to normal infection levels by the onset of patency (d60 p.i.) and
failed to enhance parasite killing. Despite the Th2 enhancing effect of agonistic anti-GITR
treatment, GITRL blockade failed to affect Th2 cell priming, and only showed a partial
effect on Th2 cell maintenance during S. mansoni infection. Thus, although super-
physiological GITR co-stimulation can enhance Th2 responses, GITR-GITRL interactions
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are not essential for the priming or maintenance of Th2 responses under physiological
conditions.
Filarial parasites have been shown to rapidly suppress host immunity (36, 49), and in
agreement with this we found that the expansion of IL-4gfp+ Th2 cells was relatively weak
in the pleural cavity (infection site) and draining LN of susceptible BALB/c mice over the
first 12 days of infection. This contrasts with the rapid expansion of CD4+Foxp3+ Tregs
seen by d7 p.i. in filarial infections (36, 50). Consistent with published work (19, 51) the
IL-4gfp+ Th2 cells increased during the later stages of infection. Agonistic anti-GITR
treatment given over the first 12 days of infection increased the quantity of IL-4gfp+ Th2
cells at the infection site, and also their functional quality as represented by an increased
ability of the IL-4gfp+ Th2 cells to secrete Th2 cytokines. Thus, GITR co-stimulation can be
used therapeutically to boost both the quantity and quality of Th2 responses towards
infection; however, this was not sufficient to enhance killing of L. sigmodontis.
The potential for using super-physiological GITR co-stimulation as a therapeutic adjuvant
has been successfully applied in a variety of tumor (52-54) and infection settings (18, 20). In
these contexts the protective effects were seen within or shortly after the duration of anti-
GITR treatment, and only one study has addressed the long-term effects of super-
physiological GITR co-stimulation (25). Immune therapies that successfully improve
protection towards L. sigmodontis often result in relatively slow killing, taking one or two
months for the effects on parasite survival to become detectable, and are associated with a
long-term enhancement of Th2 immunity (19, 36, 37). Our data with L. sigmodontis
indicates that the Th2 boosting effects of agonistic anti-GITR treatment are temporary.
Thus, the lack of efficacy of super-physiological GITR co-stimulation on L. sigmodontis
infection is likely related to the temporary nature of its Th2 promoting effect suggesting that
filarial parasites are relatively resistant to short-term enhancement of Th2 responses. This
indicates that for a therapy to be successful it needs to be able to induce a long-term change
in the protective Th2 response.
Agonistic anti-GITR treatment has been used as an adjuvant to induce long-term antibody
responses towards viral antigens (25), raising a question of why the enhancing effect on Th2
immunity towards L. sigmodontis was temporary. Filarial parasites induce a variety of
regulatory mechanisms to inhibit host immunity (1-3), in particular inducing strong Foxp3+
Treg responses (19, 36, 37, 50, 55, 56). One possibility is that once anti-GITR treatment is
discontinued parasite-induced immune suppression reasserts itself countering the enhanced
Th2 response. In support of this we find that during established L. sigmodontis infection the
efficacy of super-physiological GITR co-stimulation can be enhanced by simultaneously
depleting CD25+Foxp3+ Tregs (19). Alternatively, anti-GITR treatment may have
differential effects on Th2 versus Th1 responses. Despite the mainly Th2 nature of L.
sigmodontis infection, agonistic anti-GITR treatment resulted in a long-term elevation (up to
d60 p.i.) of Th1-associated L. sigmodontis specific IgG2a, contrasting the temporary Th2
enhancement. Thus, although GITR co-stimulation is capable of promoting both Th1 and
Th2 responses (57), it may have a more dominant effect on Th1 immunity.
Under physiological conditions the ablation of GITR-GITRL signaling is known to impair
the generation of Th1 responses in a variety of settings (13, 21, 31-33), but its requirement
for Th2 responses is unknown. Increased expression of GITR is associated with Th2
responses and resistance to L. sigmodontis both during immune priming in resistant C57BL/
6 mice, and in late-phase killing in susceptible BALB/c mice (19, 37). As GITR co-
stimulation is associated with the enhancement of immunity and abrogation of regulatory T
cell responses (14, 17, 28), this implies that GITR co-stimulation might be an important
factor in the generation of Th2 responses and natural resistance against L. sigmodontis.
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Although super-physiological GITR co-stimulation is capable of promoting Th2 responses
towards L. sigmodontis, blockade of GITR-GITRL interactions using a neutralising anti-
GITRL mAb did not inhibit the initiation of Th2 responses towards L. sigmodontis in
resistant C57BL/6 mice. Similarly, GITR-GITRL interactions were not required for the
maintenance of Th2 responses or late-phase killing in susceptible BALB/c mice. Thus,
despite its therapeutic potential, under physiological conditions GITR-GITRL interactions
do not appear to be required for protective immunity towards L. sigmodontis.
In contrast with L. sigmodontis infection, GITR-GITRL interactions were found to play a
partial role in the development of both Th2 and Th1 responses against challenge with S.
mansoni, with reduced numbers of IL-4 secreting IL-4gfp+ Th2 cells and IFN-γ secreting
CD4+ T cells in the spleen of S. mansoni infected mice following GITRL blockade. This
appeared to be more related to maintenance rather than priming of Th2 cells as GITR-
GITRL blockade did not impact upon Th2 responses following s.c. injection of S. mansoni
eggs. The effect of the antagonistic anti-GITRL mAb was relatively minor and did not
impact on Th2 cells within the liver or on the formation of Th2-induced egg granulomas
indicating that GITR-GITRL signaling is not a prominent determinant of S. mansoni
induced pathology. Thus, in contrast to its reported roles in the development of Th1
responses (13, 21, 31-33), GITR-GITRL interactions appear to be largely redundant for the
initiation and maintenance of Th2 immunity towards parasitic helminths.
Alongside co-stimulation of CD4+ effector T cells, GITR stimulation has been shown to
expand regulatory T cells in vitro (14, 43, 47, 58), although in vivo studies show conflicting
results regarding Foxp3+ Treg requirements for GITR-GITRL interactions (14, 18, 23, 47,
59, 60). Even though infection with L. sigmodontis results in the rapid expansion of
CD4+Foxp3+GITR+ Tregs at the infection site (36), agonistic anti-GITR treatment or
blocking GITR-GITRL interactions had no impact upon CD4+Foxp3+ Treg expansion.
Similarly, GITR-GITRL interactions were not required for expansion of Foxp3+ Tregs
during the acute egg-phase of S. mansoni infection. Thus, GITR-GITRL interactions are not
required for expansion of Foxp3+ Tregs during either L. sigmodontis or S. mansoni
infections.
In summary, this work indicates that super-physiological GITR co-stimulation can be used
to therapeutically enhance the quantity and quality of Th2 responses during helminth
infection. However, the temporary nature of its boosting effect is a potential limit to its
efficacy and more work is needed to identify optimal treatment regimes to promote long-
term changes in immunity. Although agonistic anti-GITR treatment enhanced Th2
responses, physiological GITR-GITRL interactions were not fundamentally required for the
priming or maintenance of Th2 responses towards either L. sigmodontis or S. mansoni.
Thus, the potent immune stimulatory properties that have been reported for super-
physiological GITR co-stimulation may not accurately reflect its actual physiological roles.
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Figure 1.
Kinetics of Th2 cell induction following L. sigmodontis infection. IL-4gfp reporter mice
were infected with L. sigmodontis (closed symbols), or left uninfected (open symbols), and
the proportion of IL-4gfp+ Th2 cells in the pleural cavity (A) and tLN (B) quantified.
Symbols represent individual mice. Lines represent means and figures show data of pooled
experiments. *p<0.05, ***p<0.001 (1-way ANOVA followed by Tukey’s HSD post-hoc
tests based on combined data from at least 2 experiments per timepoint).
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Figure 2.
Therapeutic administration of agonistic anti-GITR mAb enhances the magnitude of the Th2
response to L. sigmodontis. L. sigmodontis infected (closed symbols) BALB/c IL-4gfp
reporter mice (A-E) or BALB/c mice (F-I) were treated with agonistic anti-GITR mAb
(triangles) or rat IgG (squares) and autopsied 12 days p.i.. Open circles indicate naïve
untreated mice. Lines show mean values unless otherwise stated and symbols represent
individuals. (A-B) The proportion of CD4+ T cells expressing IL-4gfp within the pleural
cavity (A) and tLN (B). Panels show combined data from two independent experiments. (C-
E) The proportion of pleural cavity CD4+GFP+ Th2 cells producing intracellular IL-4 (C),
IL-5 (D), IL-13 (E). One representative experiment out of two shown. (F) In vitro
production of IL-5 by tLN cells following restimulation with LsAg. One of four independent
experiments shown. Lines show median values. (G) Proportion of CD4+ T cells producing
IFN-γ. (H-I) Serum levels of L. sigmodontis specific IgG1 (H) and IgG2a (I). One
representative experiment of three shown. ***p<0.001, **p<0.01 (2-way ANOVA followed
by Tukey’s HSD post-hoc test based on pooled data from denoted experiments). ΔΔ p<0.01
(Mann Whitney).
van der Werf et al. Page 16
J Immunol. Author manuscript; available in PMC 2012 July 28.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 3.
Therapeutic administration of agonistic anti-GITR during immune priming does not enhance
long-term protective Th2 immunity. L. sigmodontis infected (closed symbols) BALB/c
IL-4gfp reporter mice were treated with an agonistic anti-GITR mAb (triangles) or rat IgG
(squares) on d0 and d7 p.i. and autopsied at D60. Open circles represent naïve untreated
mice. Symbols represent individual animals, and lines represent mean values unless
otherwise stated. (A-B) The proportion of CD4+ T cells expressing GFP in the pleural cavity
(A) and tLN (B). One representative experiment of two shown. (C) In vitro production of
IL-5 by tLN cells following restimulations with LsAg. One representative experiment of
three shown, lines represent median values. (D-E) Adult parasite burden in the pleural cavity
(D) and number of Mf/ml within the peripheral blood (E). Pooled data from four
independent experiments shown. (F-G) Serum levels of L. sigmodontis-specific IgG1 (F)
and IgG2a (G). One representative experiment of two shown. (H) In vitro IFN-γ production
in response to LsAg by pooled GFP−CD4+ non-Th2 cells purified from the tLN of L.
sigmodontis infected mice treated with IgG or anti-GITR. One representative experiment of
two shown. ***p<0.001 (2-way ANOVA followed by Tukey’s HSD post-hoc tests based on
combined data from denoted experiments).
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Figure 4.
GITRL blockade during immune priming does not affect Th2 development. L. sigmodontis
infected (closed symbols) C57BL/6 mice were treated during immune priming with a
blocking anti-GITRL mAb (triangles) or rat IgG (squares) over the first 12 days of infection.
Open circles represent naïve untreated controls. (A) The proportion of Foxp3−CD4+ T cells
that incorporated BrdU. One representative experiment of three shown. ***p<0.001 (2-way
ANOVA followed by Tukey’s HSD post-hoc tests based on combined data from three
experiments). (B-C) In vitro production of IL-5 (B) and IL-13 (C) by tLN cells following
restimulation with LsAg. One representative experiment of three shown. Symbols denote
individual mice and lines show mean (A) or median (B-C) values.
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Figure 5.
GITR-GITRL interactions are not required for late-phase killing in susceptible BALB/c
mice. L. sigmodontis infected (closed symbols) BALB/c WT or BALB/c IL-4gfp reporter
mice were treated with a blocking anti-GITRL mAb (triangles) or rat IgG (squares) from
d60 to d80 p.i., and mice were autopsied on d82. Circles represent naïve untreated mice, and
symbols represent individual mice. (A-B) Adult parasite burden in the pleural cavity (A) and
Mf/ml in peripheral blood (B). One representative experiment of three shown. Lines show
mean values. (C-D) The number of CD4+GFP+ Th2 cells in the pleural cavity (C) and tLN
(D). One representative experiment of two shown, lines denote mean. (E) In vitro production
of IL-5 by tLN cells following restimulation with LsAg. One representative experiment out
of three shown, lines show median values. ***p<0.0001. (2-way ANOVA followed by
Tukey’s HSD post-hoc tests based on combined data from three experiments).
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Figure 6.
GITRL blockade impairs Th2 and Th1 responses towards S. mansoni eggs. (A-B)
Percentage of CD4+Foxp3− T cells expressing GITR in the spleen (A) and liver (B) of S.
mansoni infected (closed symbols) or naïve (open symbols) BALB/c mice 8 weeks p.i.. One
representative experiment of two shown. (C) BALB/c IL-4gfp mice were injected s.c. in the
footpad with S. mansoni eggs and treated with anti-GITRL mAb (triangles) or rat IgG
(squares) for 12 days. The numbers of IL-4gfp+ Th2 cells in the popliteal LN were
quantified at D12. One representative experiment of two shown. (D-H) S. mansoni infected
IL-4gfp mice (closed symbols) were treated with anti-GITRL mAb (triangles) or rat IgG
(squares) from wk 5 to autopsy at wk 8. Open symbols represent naïve untreated controls.
One representative experiment of two shown. (D) Total number of splenic CD4+IL-4gfp+
Th2 cells producing IL-4 protein. (E) Percentage of liver CD4+ T cells producing IL-4
protein. (F) Mean area of liver granulomas. (G) Total number of splenic CD4+ T cells
producing IFN-γ. (H) Percentage of liver CD4+ T cells producing IFN-γ. Symbols represent
individual animals and lines represent means. Δ p<0.05, ΔΔ p<0.01 (Mann-Whitney).
***p<0.001 (2-way ANOVA followed by Tukey’s HSD post-hoc tests based on combined
data from two experiments)
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FIGURE 7.
GITR-GITRL interactions are not required for expansion of Foxp3+ Tregs during helminth
infection. (A-B) Percentage of CD4+ T cells expressing Foxp3 from the pleural cavity of
resistant C57BL/6 (A) and susceptible BALB/c (B) mice infected with L. sigmodontis and
treated with a blocking anti-GITRL mAb (triangles) or agonistic anti-GITR mAb
(diamonds) respectively over the first 12 days of infection. Naïve mice are represented by
circles and IgG treated mice by squares. (C-D) Percentage of CD4+ T cells expressing
Foxp3 in the spleen (C) and liver (D) of S. mansoni infected (closed symbols) BALB/c
IL-4gfp reporter mice treated with a blocking anti-GITRL mAb (triangles) or rat IgG
(squares) from wk5 p.i. to autopsy at wk8. Open symbols represent naïve controls. One
representative experiment shown out of at least two for all panels. Symbols represent
individual mice and lines represent mean values. *p<0.05, ***p<0.001 (2-way ANOVA
followed by Tukey’s HSD post-hoc tests based on combined data from at least two
experiments).
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